Form 8-K - Current report:
SEC Accession No. 0001835567-22-000002
Filing Date
2022-01-18
Accepted
2022-01-18 08:01:44
Documents
16
Period of Report
2022-01-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pear-20220118.htm   iXBRL 8-K 40671
2 EX-99.1 PEAR THERAPEUTICS INC 2021 OPERATING RESULTS 18 JAN 2022 pear2021operatingresultspr.htm EX-99.1 36087
7 image_0a.jpg GRAPHIC 8640
8 pear-20220118_g1.jpg GRAPHIC 650556
  Complete submission text file 0001835567-22-000002.txt   1805984

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pear-20220118.xsd EX-101.SCH 2328
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pear-20220118_def.xml EX-101.DEF 16648
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pear-20220118_lab.xml EX-101.LAB 32072
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pear-20220118_pre.xml EX-101.PRE 17399
10 EXTRACTED XBRL INSTANCE DOCUMENT pear-20220118_htm.xml XML 15199
Mailing Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109
Business Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109 6469322774
Pear Therapeutics, Inc. (Filer) CIK: 0001835567 (see all company filings)

EIN.: 854103092 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39969 | Film No.: 22533667
SIC: 8000 Services-Health Services